Intellia and ONK enter licensing and collaboration agreement for allogeneic NK cell therapies Feb. 17, 2022
Alamar and SciNeuro to discover and develop novel therapeutic antibodies for neurological diseases Feb. 16, 2022
Akso and Huadong Medicine sign collaborative agreement for AB-002 in Asia Pacific region Feb. 10, 2022
Xanadu signs agreements with Yale to support development of intranasal SARS-CoV-2 vaccine booster Feb. 9, 2022
Navidea sponsors research at Penn to evaluate Tc99m tilmanocept as prognostic marker in glioblastoma Feb. 8, 2022
RSS